Experts introduce the 2026 AACE type 2 diabetes algorithm’s new classification pathway and frame misclassification—especially of adult-onset type 1 diabetes—as a central problem the update is designed to address.
Guillermo E. Umpierrez, MD, CDCES, MACP, MACE
Advertisement
Articles by Guillermo E. Umpierrez, MD, CDCES, MACP, MACE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Metreleptin-Neutralizing Antibodies Do Not Impact Treatment Outcomes in Generalized Lipodystrophy
2
Tirzepatide (Zepbound) Improves Kidney Transplant Eligibility in T2D and CKD With Severe Obesity
3
Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy
4
Diagnostic Pearls and New Therapies in Connective Tissue Disease, With Michelle Min, MD
5